Detailed information for compound 226502
Basic information
Technical information
- TDR Targets ID: 226502
- Name: 1-(2,3-dihydro-1,4-benzodioxin-8-yl)-4-[3-(2, 3-dihydro-1H-inden-2-yl)propyl]piperazine
- MW: 378.507 | Formula: C24H30N2O2
-
H donors: 0
H acceptors: 0
LogP: 4.53
Rotable bonds: 5
Rule of 5 violations (Lipinski): 1 - SMILES: C(CC1Cc2c(C1)cccc2)CN1CCN(CC1)c1cccc2c1OCCO2
- InChi: 1S/C24H30N2O2/c1-2-7-21-18-19(17-20(21)6-1)5-4-10-25-11-13-26(14-12-25)22-8-3-9-23-24(22)28-16-15-27-23/h1-3,6-9,19H,4-5,10-18H2
- InChiKey: MNFCOAQMDZUSKB-UHFFFAOYSA-N
Network
Hover on a compound node to display the structore
Synonyms
- 1-(2,3-dihydro-1,4-benzodioxin-8-yl)-4-(3-indan-2-ylpropyl)piperazine
- 1-(2,3-dihydro-1,4-benzodioxin-8-yl)-4-[3-(2-indanyl)propyl]piperazine
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Rattus norvegicus | Serotonin 1b (5-HT1b) receptor | Starlite/ChEMBL | References |
| Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Predicted pathogen targets for this compound
By orthology
By sequence similarity to non orthologous known druggable targets
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.6253 | 1 | 1 |
| Loa Loa (eye worm) | hypothetical protein | 0.3722 | 0.5704 | 0.5704 |
| Mycobacterium ulcerans | adenosine deaminase | 0.6253 | 1 | 0.5 |
| Trypanosoma cruzi | AMP deaminase, putative | 0.3851 | 0.5923 | 1 |
| Trichomonas vaginalis | adenosine deaminase, putative | 0.6253 | 1 | 0.5 |
| Entamoeba histolytica | adenosine deaminase, putative | 0.6253 | 1 | 1 |
| Leishmania major | adenine aminohydrolase | 0.6253 | 1 | 1 |
| Trichomonas vaginalis | adenosine deaminase, putative | 0.6253 | 1 | 0.5 |
| Trypanosoma brucei | AMP deaminase, putative | 0.3851 | 0.5923 | 0.5 |
| Trypanosoma brucei | AMP deaminase, putative | 0.3851 | 0.5923 | 0.5 |
| Schistosoma mansoni | AMP deaminase | 0.3851 | 0.5923 | 0.5923 |
| Treponema pallidum | adenosine deaminase | 0.6253 | 1 | 0.5 |
| Trypanosoma cruzi | adenosine monophosphate deaminase-like protein, putative | 0.3851 | 0.5923 | 1 |
| Loa Loa (eye worm) | hypothetical protein | 0.3722 | 0.5704 | 0.5704 |
| Schistosoma mansoni | adenosine deaminase | 0.6253 | 1 | 1 |
| Trypanosoma brucei | AMP deaminase, putative | 0.3851 | 0.5923 | 0.5 |
| Loa Loa (eye worm) | hypothetical protein | 0.3722 | 0.5704 | 0.5704 |
| Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.6253 | 1 | 1 |
| Echinococcus granulosus | adenosine deaminase | 0.6253 | 1 | 1 |
| Trypanosoma cruzi | adenosine monophosphate deaminase, putative | 0.3851 | 0.5923 | 1 |
| Echinococcus multilocularis | adenosine deaminase | 0.6253 | 1 | 1 |
| Onchocerca volvulus | AMP deaminase 2 homolog | 0.3851 | 0.5923 | 0.3549 |
| Schistosoma mansoni | adenosine deaminase-related | 0.6253 | 1 | 1 |
| Loa Loa (eye worm) | hypothetical protein | 0.1321 | 0.1627 | 0.1627 |
| Leishmania major | AMP deaminase, putative,adenosine monophosphate deaminase-like protein | 0.3851 | 0.5923 | 0.3549 |
| Trypanosoma cruzi | AMP deaminase, putative | 0.3851 | 0.5923 | 1 |
| Brugia malayi | adenosine monophosphate deaminase | 0.3851 | 0.5923 | 0.5923 |
| Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.6253 | 1 | 0.5 |
| Loa Loa (eye worm) | hypothetical protein | 0.6253 | 1 | 1 |
| Plasmodium vivax | adenosine deaminase, putative | 0.6253 | 1 | 1 |
| Leishmania major | AMP deaminase, putative,amp deaminase-like protein | 0.3851 | 0.5923 | 0.3549 |
| Entamoeba histolytica | adenosine deaminase, putative | 0.6253 | 1 | 1 |
| Plasmodium falciparum | adenosine deaminase | 0.6253 | 1 | 1 |
| Loa Loa (eye worm) | AMP deaminase | 0.3851 | 0.5923 | 0.5923 |
| Trypanosoma cruzi | AMP deaminase, putative | 0.3851 | 0.5923 | 1 |
| Leishmania major | AMP deaminase, putative | 0.3851 | 0.5923 | 0.3549 |
| Trypanosoma cruzi | AMP deaminase, putative | 0.3851 | 0.5923 | 1 |
| Trypanosoma cruzi | AMP deaminase, putative | 0.3851 | 0.5923 | 1 |
| Loa Loa (eye worm) | hypothetical protein | 0.253 | 0.368 | 0.368 |
| Onchocerca volvulus | Adenosine deaminase homolog | 0.6253 | 1 | 1 |
| Leishmania major | adenosine monophosphate deaminase, putative,AMP deaminase, putative | 0.3851 | 0.5923 | 0.3549 |
| Loa Loa (eye worm) | hypothetical protein | 0.3722 | 0.5704 | 0.5704 |
| Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.6253 | 1 | 0.5 |
| Trypanosoma brucei | adenosine monophosphate deaminase, putative | 0.3851 | 0.5923 | 0.5 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| ED50 (binding) | = 1.73 mg kg-1 | Induction of ptosis after subcutaneous administration of the compound at alpha-1 adrenergic receptor in rat | ChEMBL. | 7562940 |
| ED50 (binding) | = 1.73 mg kg-1 | Induction of ptosis after subcutaneous administration of the compound at alpha-1 adrenergic receptor in rat | ChEMBL. | 7562940 |
| ID50 (functional) | = 0.47 mg kg-1 | Compound after subcutaneous administration was evaluated for antagonist activity against hypothermia induced by 8-hydroxy -DPAT in rat | ChEMBL. | 7562940 |
| ID50 (binding) | > 40 mg kg-1 | Inhibitory activity against methyl-phenidate-induced gnawing at dopamine receptor D2 in rat | ChEMBL. | 7562940 |
| ID50 (binding) | > 40 mg kg-1 | Inhibitory activity against methyl-phenidate-induced gnawing at dopamine receptor D2 in rat | ChEMBL. | 7562940 |
| Ki (binding) | = -8.9 | Binding affinity at 5-hydroxytryptamine 1A receptor | ChEMBL. | 7562940 |
| Ki (binding) | = 5.73 | Binding affinity at 5-hydroxytryptamine 1B receptor | ChEMBL. | 7562940 |
| Log Ki (binding) | = 5.23 | Binding affinity at 5-hydroxytryptamine 1B receptor | ChEMBL. | 7562940 |
| Log Ki (binding) | = 8.9 | Binding affinity at 5-hydroxytryptamine 1A receptor | ChEMBL. | 7562940 |
| Max effect (functional) | = 40 % | Maximum agonist effect (% effect) expressed relative to 8-hydroxy-DPAT (100%) | ChEMBL. | 7562940 |
| Max effect (functional) | = 70 % | Maximum antagonist effect (% effect) expressed relative to 8-hydroxy-DPAT (100%) | ChEMBL. | 7562940 |
| MED (functional) | = 0.63 mg kg-1 | Minimum effective antagonist dose administered subcutaneously | ChEMBL. | 7562940 |
| MED (functional) | = 40 mg kg-1 | Minimum effective agonist dose administered subcutaneously | ChEMBL. | 7562940 |
| Ratio (functional) | = 63.5 | Ratio of MED (agonist) to that of MED (antagonist) values. | ChEMBL. | 7562940 |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL130103
- PubChem: 10068238
Bibliographic References
1 literature reference was collected for this gene.
If you have references for this compound, please enter them in a user comment (below) or Contact us.